We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Waters Welcomes Duke University Proteomics Core Facility into Centers of Innovation Program
News

Waters Welcomes Duke University Proteomics Core Facility into Centers of Innovation Program

Waters Welcomes Duke University Proteomics Core Facility into Centers of Innovation Program
News

Waters Welcomes Duke University Proteomics Core Facility into Centers of Innovation Program

Read time:
 

Waters Corporation has welcomed into its Centers of Innovation Program the Proteomics Core Facility at the Duke University School of Medicine (Durham, NC).

In a ceremony at Duke University, Waters recognized Associate Research Prof. M. Arthur Moseley, Director of Proteomics, for his research and support of ongoing research at the Duke University School of Medicine to bring about improvements in human health.

Proteomics is a burgeoning science focused largely on an understanding of protein functions and structures and the interplay between genes and proteins and protein/protein interactions that play a key role in causing and preventing disease.

“We consider the Proteomics Core Facility led by Dr. Moseley to be our flagship core facility,” said Sally Kornbluth, Ph.D., Vice Dean for Research, Duke University. “Our vision was to create an intellectual resource and equip it so that we could provide our biomedical researchers the best possible analytical results. Under Arthur’s direction its value has increased exponentially.”

“With the Proteomics Core Facility our intention was always to provide the highest quality data anywhere in the world for the least expensive price," said Associate Research Prof. Arthur Moseley.

Moseley continued, "My team and I have had the opportunity to work with some of the sharpest biomedical researchers in the field working on an incredible variety of projects. With the liquid chromatography and mass spectrometry instrumentation we have today, we can ask much more meaningful questions, questions relating to the fundamentals of biology, how proteins interact, how protein expression levels change as a function of a disease state or as a function of drug administration. These technologies put Duke ahead of the curve when it comes to commercially available state-of-the-art proteomic technologies.”

“Dr. Moseley’s expertise and knowledge in the area of applied mass spectrometry have earned him the respect of scientists around the world. We support the efforts of scientists like him for help in turning the corner on cancer and infectious diseases,” said Tim Riley, Vice President and Director, Centers of Innovation Program at Waters. “Our relationship with Arthur epitomizes a successful corporate/academic collaboration.”

Advertisement